FAP and cancer: Radionuclide-labelled fibroblast-activated protein inhibitors, such as [68Ga]fibroblast-activated protein inhibitor ([68Ga]Ga-FAPI), have emerged as PET tracers targeting FAP, demonstrating superiority over [18F]FDG in imaging various cancers (11, 16, 17).